IGF2BP2 and metabolic dysfunction-associated steatohepatitis: Further, transgenic overexpression of the IGF2 mRNA binding protein (IGF2BP2/IMP2), leading to upregulated expression of H19, induces steatosis [46] and promotes NASH progression [47,48].